AEHR vs PATH · P/E 16, rev $59.0M vs P/E 19, rev $1.61B
Aehr Test Systems (AEHR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Aehr Test Systems (AEHR) is a semiconductor equipment & materials company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AEHR revenue for 2025-05-30 was $59.0M. Net income was -$3.9M. Revenue was down 10.9% from 2024-05-31 to 2025-05-30. AEHR currently screens at market cap $384.9M and trailing P/E 16.0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AEHR currently screens at market cap $384.9M and trailing P/E 16.0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AEHR and PATH stock pages for the full models.
Not investment advice.